CIK 0001819133 · Non-accelerated filer<br>Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (857) 320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,858,086
- in 6 filings, $1.9M under 10b5-1 plans
Net −$1,858,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-06 | Weber Barbara Chief Executive Officer | Sale | −4,681 | $12.56 | $59K | 1,539,624 |
| 2024-02-06 | Barry Douglas General Counsel | Sale | −1,422 | $12.56 | $18K | 45,335 |
| 2024-02-06 | Beckman Daniella Chief Financial Officer | Sale | −1,908 | $12.56 | $24K | 134,214 |
| 2024-02-06 | Crystal Adam See Remarks | Sale | −4,288 | $12.56 | $54K | 123,561 |
| 2024-02-01 | Beckman Daniella Chief Financial Officer | Grant or award | +39,413 | 39,413 | ||
| 2024-02-01 | Beckman Daniella Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +236,475 | 236,475 | ||
| 2024-02-01 | Crystal Adam See Remarks | Grant or award | +46,599 | 46,599 | ||
| 2024-02-01 | Crystal Adam See Remarks | Grant or award · Stock Option (Right to Buy) | +279,593 | 279,593 | ||
| 2024-02-01 | Weber Barbara Chief Executive Officer | Grant or award | +87,168 | 87,168 | ||
| 2024-02-01 | Weber Barbara Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +523,012 | 523,012 | ||
| 2024-02-01 | Barry Douglas General Counsel | Grant or award | +22,859 | 22,859 | ||
| 2024-02-01 | Barry Douglas General Counsel | Grant or award · Stock Option (Right to Buy) | +137,156 | 137,156 | ||
| 2023-11-01 | Crystal Adam See Remarks | Sale | −7,507 | $8.39 | $63K | 81,250 |
| 2023-10-16 | Boxer Capital, LLC See remarks | Purchase | +500,000 | $6.84 | $3.4M | 8,198,642 |
| 2023-10-16 | Boxer Capital, LLC See remarks | Purchase 10b5-1 | +500,000 | $6.84 | $3.4M | 8,198,642 |
| 2023-10-13 | Boxer Capital, LLC See remarks | Purchase | +750,000 | $7.07 | $5.3M | 7,698,642 |
| 2023-10-13 | Boxer Capital, LLC See remarks | Purchase 10b5-1 | +750,000 | $7.07 | $5.3M | 7,698,642 |
| 2023-10-09 | Boxer Capital, LLC See remarks | Sale | −50,000 | $9.91 | $496K | 693,524 |
| 2023-10-09 | Boxer Capital, LLC See remarks | Sale | −175,000 | $9.97 | $1.7M | 6,948,642 |
| 2023-08-29 | Ketchum John B Director | Grant or award | +10,000 | 10,000 |
Page 9 of 11 · 211 trades